1 |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版) [J]. 中华消化外科杂志, 2022, 21(2): 143-168.
|
2 |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries [J]. Lancet Glob Health, 2018, 6(5): e555-e567.
|
3 |
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma [J]. Hepatology, 2018, 67(1): 358-380.
|
4 |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? [J]. Cancer Commun (Lond), 2019, 39(1): 22.
|
5 |
Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior [J]. J Cancer Res Clin Oncol, 2011, 137(4): 567-575.
|
6 |
中国医师协会超声医师分会. 中国超声造影临床应用指南 [M]. 北京: 人民卫生出版社, 2017: 85-93.
|
7 |
Christoph CF, Nols NCP, Barr RG, et al. Guideline and good clinical practical practice recommendations for contrast-enhanced ultrasound (ceus) in the liver-update 2020 wfumb in cooperation with efsumb, afsumb, aium, and flaus [J]. Ultrasound Med Biol, 2020, 46(10): 2579-2604.
|
8 |
丁红. 肝脏超声造影临床应用指南(2012)解读 [J/CD]. 中华医学超声杂志(电子版), 2014, 11(2): 99-101.
|
9 |
中华医学会肝病学分会肝癌学组. 肝细胞癌癌前病变的诊断和治疗多学科专家共识(2020版) [J]. 临床肝胆病杂志, 2020, 36(3): 514-518.
|
10 |
Lee YB, Ha Y, Chon YE, et al. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B [J]. Clin Mol Hepatol, 2019, 25(1): 52-64.
|
11 |
任新平, 林艳艳, 郑丽丽, 等. 超声造影在脂肪肝背景下肝局灶性病变诊断中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2020, 17(9): 834-840.
|
12 |
费翔, 罗渝昆, 李楠, 等. 高帧频超声造影在肝富血供占位性病变 动脉期中的成像优势与临床价值 [J/OL]. 中华医学超声杂志(电子版), 2020, 17(9): 827-833.
|
13 |
戴全, 戴海鹏, 刘冬梅, 等. 实时超声造影鉴别诊断脂肪肝背景下肝内低回声病变良恶性的临床价值 [J]. 实用肿瘤学志, 2014(5): 415-419.
|
14 |
张丽丽, 顾金花, 齐云峰, 等. 不同肝背景下原发性肝癌超声造影灌注特征的定量分析 [J]. 吉林大学学报(医学版), 2016, 42(1): 164-167.
|